USDNew York Stock ExchangeDelayed PriceMarket Closed Earnings High Target Price 42.00 Mean Target Price 27.50 Low Target Price 16.00 Standard Deviation: 7.43 Number of Estimates 14 Date of Most Recent Estimate 01/31/25 Price Estimate# EstimatesHighMeanLow# Estimates3 Week2 Week1 WeekCurrent0102030405...
Price Target Updated: Jan 27, 2025 6.8517.8528.8539.8550.40Past 12 Months12 Months ForecastMax42.00Avg29.18Min18.00Current30.51 Unlock Price Targets Trade Overview Unit: M Net Inflow 5.14 4.30%9.52%11.06%23.40%24.89%13.17%10.04%3.63% Inflow:76.94 ...
Hims & Hers Health, Inc. (NYSE:HIMS) Receives $24.80 Consensus Target Price from Analysts January 13at1:31 AM | americanbankingnews.com See More Headlines HIMS Stock Analysis - Frequently Asked Questions The Best High-Yield Dividend Stocks for 2024 ...
USDNew York Stock ExchangeDelayed PriceMarket Closed Earnings High Target Price 42.00 Mean Target Price 27.50 Low Target Price 16.00 Standard Deviation: 7.43 Number of Estimates 14 Date of Most Recent Estimate 01/22/25 # Estimates: 141015202530354045 Mean27.50 High42.00 Low16.00 Price Estimate# Estima...
Biotech and PharmaNovo Nordisk Stock Slumps As Wegovy Sales Disappoint Aug. 7, 2024 at 11:17 a.m. ETby Barron's Other NewsPress Releases Hims & Hers Health Inc (HIMS) Stock Price Down 4.82% on Jan 10 Jan. 10, 2025 at 12:20 p.m. ETon GuruFocus.com ...
Citi Downgrades Hims & Hers Health(HIMS.US) to Sell Rating, Raises Target Price to $25 Futu NewsJan 10 18:32· Ratings What's Going On With Hims & Hers Health Stock? BenzingaJan 10 02:25 Wall Street's Riskiest Stocks Are Melting Down as Retail Traders Face 'Day of Reckoning' Market...
Biotech and PharmaNovo Nordisk Stock Slumps As Wegovy Sales Disappoint Aug. 7, 2024 at 11:17 a.m. ETby Barron's Other NewsPress Releases Hims & Hers Health Inc (HIMS) Stock Price Down 4.82% on Jan 10 Jan. 10, 2025 at 12:20 p.m. ETon GuruFocus.com ...
Stock Price26.90 Revenue$0000 View About Hims Hims (NYSE: HIMS) offers a multi-specialty telehealth platform. The company offers online consultations and personalized treatment plans for a range of conditions, including sexual health, hair care, mental health, and skincare, primarily serving individua...
Currently, the analyst consensus on Hims & Hers Health is a Moderate Buy with an average price target of $22.82, which is a 9.92% upside from current levels. In a report released today, Piper Sandler also maintained a Hold rating on the stock with a $21.00 price target. See Insiders’ ...
USDNew York Stock ExchangeDelayed Price Earnings High Target Price 42.00 Mean Target Price 27.50 Low Target Price 16.00 Standard Deviation: 7.43 Number of Estimates 14 Date of Most Recent Estimate 02/05/25 Price Estimate# EstimatesHighMeanLow# Estimates3 Week2 Week1 WeekCurrent0102030405013.51414.5151...